Michael Mentesana

Part of Siemens AG, OpTx Corp. is a company that provides oncology-specific software and services providers. The company is based in Englewood, CO. OpTx was acquired by Varian Medical Systems, Inc., part of Siemens AG from April 15, 2021 on March 29, 2004 for $18 million. The company was founded by Gerald Hogue.

Saama Technologies, Inc. engages in the provision of consulting and systems integration services. It offers study conduct, study planning, and real world and commercial insight solutions The company was founded by Suresh Katta in 1997 and is headquartered in Campbell, CA.

Bridgesite Clinical Research, Inc. engages in the provision of clinical research services. The company was founded by Thomas J. Baxter and is headquartered in Columbus, OH.

Florida Cancer Specialists PL provides health care services. It services include clinical trials, diagnostic imaging, oncology program, pathology lab, nursing, and related services. The company was founded by William N. Harwin in 1984 and is headquartered in Fort Myers, FL.

Syapse, Inc. develops software solutions that enable healthcare providers to deploy precision medicine programs. Its medical platform is used to integrate complex genomic and clinical data to provide clinicians with actionable insights at point of care, enabling diagnosis, treatment, and outcomes tracking. The firm offers a suite of clinical applications built on the Syapse Precision Medicine Platform and designed to help healthcare providers implement and scale precision medicine at the point of care. The company was founded by Tony Loeser, Glenn S. Winokur, and Jonathan Hirsch in 2008 and is headquartered in San Francisco, CA.

Octave Bioscience, Inc. operates as an early-stage diagnostics company which provides healthcare services. It focuses on neurodegenerative diseases and conditions. The company was founded by William A. Hagstrom in 2014 and is headquartered in Menlo Park, CA.

NanoView Biosciences, Inc. engages in research and development of non technology. It develops ExoView platform that provides critical information that will assist in the translation of extracellular vesicle research into the clinical and therapeutic environment. The company was founded by David Freedman and George G. Daaboul and is headquartered in Boston, MA.

Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland.

Scitara Corp. operates as a cloud based connectivity platform that transforms integration between instruments and lab informatics applications. It offers implementation, validation services, dlx platform development and integration, cloud integration and transitions. The company was founded by Ajit Nagral and Geoff Gerhardt and is headquartered in Marlborough, MA.

Vizgen, Inc. engages in business of biotechnology. The company was founded in 2019 and is headquartered in Cambridge, MA.

Outcomes4me, Inc. develops healthcare platform services. The company was founded by Maya R. Said and Osama E. Rahma in and is headquartered in Cambridge, MA.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

American Oncology Network LLC is a rapidly expanding organization that represents 106 physicians and 86 nurse practitioners and physician assistants practicing across 18 states. The company is based in Fort Myers, FL. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on providing the highest quality care for patients. AON provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. Todd Schonherz has been the CEO of the company since 2017.

Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.